Population-Specific Exploration of MIR146A Gene Polymorphism in Acute Renal Rejection: A Cross-Sectional,

Nor Elhouda Nacer1,2, Soumia Missoum3,4, Houssem Eddine Ouarhlent3,4

  • 1Laboratory of Acquired and Constitutional Genetic Diseases (MAGECA), Faculty of Medicine, University of Batna 2, Batna 05000, Algeria.

Insights

The rs2910164 polymorphism in the MIR146A gene is not associated with acute renal allograft rejection (AR) in kidney transplant recipients. This study provides population-specific data suggesting no link between this microRNA SNP and AR risk.

Area of Science:

  • Immunogenetics
  • Transplantation immunology
  • Molecular biology

Background:

  • Acute renal allograft rejection (AR) is a major complication following kidney transplantation, driven by immune responses.
  • MicroRNAs are emerging as critical immune modulators, but their role in AR and specific genetic variants like the MIR146A rs2910164 polymorphism remain unclear.
  • Previous studies on the association between MIR146A rs2910164 and AR have yielded few and conflicting results.

Purpose of the Study:

  • To investigate the association between the MIR146A gene single-nucleotide polymorphism rs2910164 (C>G) and the risk of acute renal allograft rejection (AR).
  • To analyze potential confounding factors, including donor-recipient age difference, donor-specific antibodies (DSAs), HLA mismatches, and post-transplant viral infections, in relation to AR.
  • To provide population-specific data on the genetic contribution to AR susceptibility.

Main Methods:

  • A cohort study involving 533 kidney transplant recipients (KTRs) was conducted.
  • Genotyping for the MIR146A rs2910164 polymorphism was performed using real-time PCR in patients with biopsy-proven late AR (n=35) and matched controls without AR (n=60).
  • Statistical analyses included multivariable logistic regression and Firth penalized logistic regression, adjusting for relevant clinical and immunological factors.

Main Results:

  • The donor-recipient age difference was significantly higher in the AR group compared to the non-AR group (p < 0.001).
  • AR was significantly associated with preformed donor-specific antibodies (DSAs) (OR = 9.263) and two HLA-A* mismatches (OR = 6.000).
  • Post-transplant viral infections, including CMV and SARS-CoV-2, were also associated with AR (p < 0.05). Crucially, the rs2910164 polymorphism showed no significant association with AR across all tested genetic models (p > 0.05).

Conclusions:

  • The MIR146A rs2910164 polymorphism is not associated with acute renal allograft rejection in the studied cohort of kidney transplant recipients.
  • Factors such as donor-recipient age difference, DSAs, HLA mismatches, and viral infections are significant risk factors for AR.
  • Larger, multicenter studies and meta-analyses are warranted to definitively confirm these findings and explore potential modest or context-dependent effects of rs2910164 on AR.